Showing results (381-390 of 441) with videos related to

Sort By:
Pageof 45
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2014
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classificationsBas W G van Rhijn, Mireia Musquera, Liyang Liu, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
Urology|April 18, 2025
Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease vs Persistent Muscle-Invasive DiseaseAndres M Acosta, Mohammed Saad, Alcides Chaux, et al.
Human Reproduction (Oxford, England)|July 23, 2018
Association of culture medium with growth, weight and cardiovascular development of IVF children at the age of 9 yearsH Zandstra, L B P M Brentjens, B Spauwen, et al.
Cells|November 26, 2022
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingAnnelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, et al.
Prostate Cancer and Prostatic Diseases|November 16, 2018
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factorsHanneke Jansen, Inge M van Oort, George van Andel, et al.
Plos One|January 16, 2013
Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancerWouter Bult, Stephanie G C Kroeze, Mattijs Elschot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cellsMaud Rijnders, Hayri E Balcioglu, Debbie G J Robbrecht, et al.
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
Oncoimmunology|July 8, 2022
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtypeSandra van Wilpe, Donjetë Simnica, Peter Slootbeek, et al.
Pageof 45